Edopathal 1 mg Tablet (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and an adequate clinical response is not observed, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be used in certain patients. It should not be taken if there is an allergy to its active ingredient or other components. Additionally, patients currently taking or recently discontinued other MAO inhibitors or certain herbal medicines should not use this drug. It should particularly not be administered to patients currently taking or recently stopped medications such as meperidine, tramadol, or dextromethorphan. Patients with moderate to severe liver dysfunction should also not take this medication. Caution is needed when using this medication, as various side effects may occur. Common side effects may include headache, dizziness, nausea, insomnia, musculoskeletal pain, skin rash, and blood pressure changes. Additionally, mental and neurological problems such as hallucinations, depression, movement disorders, low blood pressure, and impulse control disorders may occur. If these symptoms appear, immediate consultation with healthcare professionals is necessary. Patients with impaired liver or kidney function require special attention to dosage adjustment or use of this medication. It is especially recommended not to use this medication in patients with moderate to severe hepatic impairment. This medication may interact with other drugs, so it is essential to inform your doctor or pharmacist if you are taking any medications. Special caution is advised when taken with MAO inhibitors, antidepressants, analgesics, cold medications, and blood pressure medications. Women who are pregnant or breastfeeding should consult with healthcare professionals before taking this medication, as there is limited information on its effects on fetuses or newborns. The safety and efficacy of this medication in children under 18 years of age have not been established, and its use is not recommended. Seniors aged 65 and older can use this medication without special dosage adjustments, but caution may be needed based on their condition. In cases of overdose, serious side effects can occur, so it is essential to adhere strictly to the recommended dosage, and if an overdose occurs, immediate medical attention is required. During treatment, caution is advised as drowsiness or decreased concentration may occur during activities such as driving or operating machinery. Finally, this medication should be stored out of reach of children, in a suitable temperature between 1-25 degrees Celsius, and should not be transferred to another container.

Influenza

This medication should be stored in a tightly closed container to protect it from air and moisture. The appropriate storage temperature is in a cool place between 1 degree and 25 degrees.

Appearance

Flat round tablets with edges, white or almost white

Package unit

10 tablets/PTP [10 tablets/PTP*1], 30 tablets/PTP [10 tablets/PTP*3], 10 tablets/bottle, 30 tablets/bottle, 100 tablets/bottle